ASP Isotopes Inc. (NASDAQ:ASPI) Shares Purchased by HTLF Bank

HTLF Bank increased its stake in shares of ASP Isotopes Inc. (NASDAQ:ASPI) by 197.0% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 105,538 shares of the company’s stock after purchasing an additional 70,000 shares during the period. HTLF Bank owned 0.16% of ASP Isotopes worth $323,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the business. Virtu Financial LLC raised its holdings in ASP Isotopes by 477.0% in the 1st quarter. Virtu Financial LLC now owns 83,677 shares of the company’s stock valued at $346,000 after acquiring an additional 69,176 shares during the last quarter. Vanguard Group Inc. boosted its position in ASP Isotopes by 479.1% during the 1st quarter. Vanguard Group Inc. now owns 1,021,019 shares of the company’s stock worth $4,217,000 after purchasing an additional 844,705 shares during the period. Finally, Rathbones Group PLC purchased a new stake in ASP Isotopes during the 4th quarter worth $272,000. 16.80% of the stock is currently owned by institutional investors and hedge funds.

ASP Isotopes Stock Up 7.9 %

ASP Isotopes stock traded up $0.19 during trading on Friday, reaching $2.59. 204,055 shares of the company’s stock were exchanged, compared to its average volume of 810,875. The company’s 50-day moving average is $2.85 and its two-hundred day moving average is $3.50. The company has a debt-to-equity ratio of 1.70, a quick ratio of 3.57 and a current ratio of 3.57. ASP Isotopes Inc. has a 52-week low of $0.84 and a 52-week high of $5.67. The firm has a market cap of $134.07 million, a price-to-earnings ratio of -4.89 and a beta of 5.16.

ASP Isotopes (NASDAQ:ASPI) last posted its quarterly earnings data on Monday, August 19th. The company reported ($0.24) earnings per share for the quarter. The business had revenue of $1.02 million for the quarter. On average, analysts predict that ASP Isotopes Inc. will post -0.11 earnings per share for the current year.

Wall Street Analyst Weigh In

Separately, HC Wainwright decreased their price target on shares of ASP Isotopes from $5.50 to $4.50 and set a “buy” rating for the company in a research report on Wednesday, August 7th.

Insider Buying and Selling at ASP Isotopes

In other news, major shareholder Ak Jensen Investment Managemen acquired 61,849 shares of the firm’s stock in a transaction on Wednesday, July 10th. The stock was bought at an average cost of $3.40 per share, with a total value of $210,286.60. Following the transaction, the insider now directly owns 6,678,723 shares in the company, valued at approximately $22,707,658.20. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 26.30% of the stock is currently owned by corporate insiders.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.